Unlocking the potential of lipid-based nanoparticles for intranasal drug delivery in Parkinson’s disease

Key Points

• Lipid-based nanoparticles improve drug delivery efficiency in Parkinson's disease, enhancing bioavailability.
• Increased brain targeting compared to traditional methods contributes to better therapeutic effects.
• Assessment using lipid-based nanoparticle formulations shows improved absorption and transport across the nasal mucosa.
• Such advancements may enable more effective non-invasive treatments for neurological disorders.